🇦🇺 Australia Country × Condition
mantle cell lymphoma Clinical Trials in Australia
Active clinical trials for mantle cell lymphoma with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1, Phase 2, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇦🇺 Australia
Active Trials in Australia (3)
NCT05006716 Phase 1, Phase 2
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Enrollment
645 pts
Country
🇦🇺 Australia
BeOne Medicines
View Trial → NCT05833763 Phase 2
Recruiting
A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.
Enrollment
42 pts
Country
🇦🇺 Australia
Australasian Leukaemia and Lymphoma...
View Trial → NCT05365659 Phase 1
Recruiting
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Enrollment
140 pts
Country
🇦🇺 Australia
Iksuda Therapeutics Ltd.
View Trial → Frequently Asked Questions
How many mantle cell lymphoma clinical trials are active in Australia?
There are currently 3 active clinical trials for mantle cell lymphoma with sites in Australia, of which 3 are actively recruiting patients.
How can I join a mantle cell lymphoma clinical trial in Australia?
To join a mantle cell lymphoma clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are mantle cell lymphoma trials in Australia?
Active mantle cell lymphoma trials in Australia span Phase 1, Phase 2, Phase 2, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology